APA (7th ed.) Citation

Saif, M. S. I., Sehgal, K., Zhang, Z., Butler, R. A., Wiencke, J. K., Molinaro, A. M., . . . Kelsey, K. T. (2026). A cytokine-based serum proteomic score is a prognostic biomarker for immunotherapy in head and neck cancer. Cancer Immunology, Immunotherapy, 75(1), 1. https://doi.org/10.1007/s00262-025-04271-1

Chicago Style (17th ed.) Citation

Saif, Md Saiful Islam, et al. "A Cytokine-based Serum Proteomic Score Is a Prognostic Biomarker for Immunotherapy in Head and Neck Cancer." Cancer Immunology, Immunotherapy 75, no. 1 (2026): 1. https://doi.org/10.1007/s00262-025-04271-1.

MLA (9th ed.) Citation

Saif, Md Saiful Islam, et al. "A Cytokine-based Serum Proteomic Score Is a Prognostic Biomarker for Immunotherapy in Head and Neck Cancer." Cancer Immunology, Immunotherapy, vol. 75, no. 1, 2026, p. 1, https://doi.org/10.1007/s00262-025-04271-1.